The Center for Advanced Heart Failure, Mechanical Circulatory Support and Heart Transplantation provides comprehensive evaluation, management and treatment for patients with heart failure. The Center is the model for innovative, evidence-based medical care, where a collaborative multidisciplinary partnership is practiced and patients have access to the full spectrum of life-saving heart care, ranging from the least-invasive drug therapies to state-of-the art surgery, including transplant.
Experience and Specialty Areas
The Center's multidisciplinary team is composed of specialists representing every aspect of cardiac care, including heart failure cardiologists, electrophysiologists, cardiac surgeons, as well as dedicated nurse practitioners, nurse coordinators, pharmacists, financial counselors, a social worker, a dietician, palliative care specialists, transplant immunologists, intensivists, psychologists and exercise physiologists. The Center is often among the first in the country to use new medicines, procedures and devices for every degree of heart failure and is involved in multiple clinical trials. Our goal is to provide each patient a tailored plan of treatment addressing their physical, mental and emotional needs with nurse-led clinics, telemanagement, nutrition counseling and social services.
Surviving Heart Failure
Three patients describe their treatment at Yale-New Haven Hospital's Center for Advanced Heart Failure. Greg Kelly, Frank Coteron and Bob Tilton each faced life-threatening heart conditions, but were able to resume normal living after complex procedures performed by Yale-New Haven Hospital surgeons.
Treatment options available to patients include:
- Evaluation and medical tailored therapy for advanced heart failure
- Cardiac resynchronization therapy
- Implantable cardioverter defibrillators
- Ablation therapy for atrial and ventricular arrhythmias
- High risk coronary revascularization and valve repair in carefully selected patients
- Complex and reoperative heart operations
- Cardiac transplantation
- Left ventricular assist devices (LVADs)
- Extracorporeal membrane oxygenation (ECMO)
- Septal myectomy and surgical treatment of left ventricular out-flow tract obstruction
- Advanced care planning
- Opportunity for participation in a wide range of clinical research activities
- Monthly support and education classes
- Off-pump bypass grafting
- Post-cardiotomy shock
- Cardiac rehabilitation for patients living with heart failure
LVAD as a permanent solution
Yale-New Haven Hospital (YNHH) has received certification from the Joint Commission - the nation's predominant standards-setting and accrediting body in health care - to implant left ventricular assist devices (LVADs) into patients with end-stage heart failure as a permanent or destination therapy, not just as a temporary bridge to transplant..